Detalhe da pesquisa
1.
Final overall survival analysis of the phase 3 HERITAGE study demonstrates equivalence of trastuzumab-dkst to trastuzumab in HER2-positive metastatic breast cancer.
Breast Cancer Res Treat
; 188(2): 369-377, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34125340
2.
Statistical approach to quality assessment in liver transplantation.
Langenbecks Arch Surg
; 403(1): 61-71, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28889185
3.
Prognostic factors for long-term survival after adult liver transplantation.
Langenbecks Arch Surg
; 403(4): 495-508, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29610975
4.
Correlation between week 24 trastuzumab-dkst response and week 48 progression-free survival: the HERITAGE trial.
Breast
; 58: 18-26, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33892316
5.
Risk Balancing of Cold Ischemic Time against Night Shift Surgery Possibly Reduces Rates of Reoperation and Perioperative Graft Loss.
J Transplant
; 2017: 5362704, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28203455
6.
Matched-pair analysis: identification of factors with independent influence on the development of PTLD after kidney or liver transplantation.
Transplant Res
; 5: 6, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27486513
7.
New Fixed-Dose Combinations of Fenofibrate/Simvastatin Therapy Significantly Improve the Lipid Profile of High-Risk Patients with Mixed Dyslipidemia Versus Monotherapies.
Cardiovasc Ther
; 33(6): 329-37, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26227087